|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J
Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grozinger CM, Hassig CA and Schreiber SL:
Three proteins define a class of human histone deacetylases related
to yeast Hda1p. Proc Natl Acad Sci USA. 96:4868–4873. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marks P, Rifkind RA, Richon VM, Breslow R,
Miller T and Kelly WK: Histone deacetylases and cancer: Causes and
therapies. Nat Rev Cancer. 1:194–202. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seidel C, Schnekenburger M, Dicato M and
Diederich M: Histone deacetylase 6 in health and disease.
Epigenomics. 7:103–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valenzuela-Fernández A, Cabrero JR,
Serrador JM and Sánchez-Madrid F: HDAC6: A key regulator of
cytoskeleton, cell migration and cell-cell interactions. Trends
Cell Biol. 18:291–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng Q and Wang X: Autophagy and the
ubiquitin-proteasome system in cardiac dysfunction. Panminerva Med.
52:9–25. 2010.PubMed/NCBI
|
|
8
|
Aldana-Masangkay GI and Sakamoto KM: The
role of HDAC6 in cancer. J Biomed Biotechnol. 2011:8758242011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bienz M and Clevers H: Linking colorectal
cancer to Wnt signaling. Cell. 103:311–320. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen C, Xue Y, Zhang D, Xu W, Xu H, Yao H,
Pei D and Gu Y: Short hairpin RNA silencing of TGF-βRII and FZD-7
synergistically suppresses proliferation and metastasis of
hepatocellular carcinoma cells. Oncol Lett. 11:2039–2046. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tian Y, Mok MT, Yang P and Cheng AS:
Epigenetic activation of Wnt/β-catenin signaling in
NAFLD-associated hepatocarcinogenesis. Cancers (Basel). 8:E762016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu C, Li Y, Semenov M, Han C, Baeg GH,
Tan Y, Zhang Z, Lin X and He X: Control of beta-catenin
phosphorylation/degradation by a dual-kinase mechanism. Cell.
108:837–847. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ikeda S, Kishida S, Yamamoto H, Murai H,
Koyama S and Kikuchi A: Axin, a negative regulator of the Wnt
signaling pathway, forms a complex with GSK-3beta and beta-catenin
and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
EMBO J. 17:1371–1384. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu J, Coyne CB and Sarkar SN: PKC alpha
regulates Sendai virus-mediated interferon induction through HDAC6
and β-catenin. EMBO J. 30:4838–4849. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding G, Liu HD, Huang Q, Liang HX, Ding
ZH, Liao ZJ and Huang G: HDAC6 promotes hepatocellular carcinoma
progression by inhibiting P53 transcriptional activity. FEBS Lett.
587:880–886. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanno K, Kanno S, Nitta H, Uesugi N, Sugai
T, Masuda T, Wakabayashi G and Maesawa C: Overexpression of histone
deacetylase 6 contributes to accelerated migration and invasion
activity of hepatocellular carcinoma cells. Oncol Rep. 28:867–873.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jung KH, Noh JH, Kim JK, Eun JW, Bae HJ,
Chang YG, Kim MG, Park WS, Lee JY, Lee SY, et al: Histone
deacetylase 6 functions as a tumor suppressor by activating c-Jun
NH2-terminal kinase-mediated beclin 1-dependent autophagic cell
death in liver cancer. Hepatology. 56:644–657. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bae HJ, Jung KH, Eun JW, Shen Q, Kim HS,
Park SJ, Shin WC, Yang HD, Park WS, Lee JY and Nam SW: MicroRNA-221
governs tumor suppressor HDAC6 to potentiate malignant progression
of liver cancer. J Hepatol. 63:408–419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv Z, Weng X, Du C, Zhang C, Xiao H, Cai
X, Ye S, Cheng J, Ding C, Xie H, et al: Downregulation of HDAC6
promotes angiogenesis in hepatocellular carcinoma cells and
predicts poor prognosis in liver transplantation patients. Mol
Carcinog. 55:1024–1033. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Zhang X, Polakiewicz RD, Yao TP and
Comb MJ: HDAC6 is required for epidermal growth factor-induced
beta-catenin nuclear localization. J Biol Chem. 283:12686–12690.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mak AB, Nixon AM, Kittanakom S, Stewart
JM, Chen GI, Curak J, Gingras AC, Mazitschek R, Neel BG, Stagljar I
and Moffat J: Regulation of CD133 by HDAC6 promotes β-catenin
signaling to suppress cancer cell differentiation. Cell Rep.
2:951–963. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vasko V, Espinosa AV, Scouten W, He H,
Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la
Chapelle A, et al: Gene expression and functional evidence of
epithelial-to-mesenchymal transition in papillary thyroid carcinoma
invasion. Proc Natl Acad Sci USA. 104:2803–2088. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Todaro M, Iovino F, Eterno V, Cammareri P,
Gambara G, Espina V, Gulotta G, Dieli F, Giordano S, De Maria R and
Stassi G: Tumorigenic and metastatic activity of human thyroid
cancer stem cells. Cancer Res. 70:8874–8885. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Salminen A, Kauppinen A and Kaarniranta K:
AMPK/Snf1 signaling regulates histone acetylation: Impact on gene
expression and epigenetic functions. Cell Signal. 28:887–895. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park G, Tan J, Garcia G, Kang Y, Salvesen
G and Zhang Z: Regulation of histone acetylation by autophagy in
Parkinson disease. J Biol Chem. 291:3531–3540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Witt O, Deubzer HE, Milde T and Oehme I:
HDAC family: What are the cancer relevant targets? Cancer Lett.
277:8–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee JY, Kuo CW, Tsai SL, Cheng SM, Chen
SH, Chan HH, Lin CH, Lin KY, Li CF, Kanwar JR, et al: Inhibition of
HDAC3- and HDAC6-promoted survivin expression plays an important
role in SAHA-induced autophagy and viability reduction in breast
cancer cells. Front Pharmacol. 7:812016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lim JA and Juhnn YS: Isoproterenol
increases histone deacetylase 6 expression and cell migration by
inhibiting ERK signaling via PKA and Epac pathways in human lung
cancer cells. Exp Mol Med. 48:e2042016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hackanson B, Rimmele L, Benkißer M,
Abdelkarim M, Fliegauf M, Jung M and Lübbert M: HDAC6 as a target
for antileukemic drugs in acute myeloid leukemia. Leuk Res.
36:1055–1062. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang SH, Li N, Wei Y, Li QR and Yu ZP:
β-catenin deacetylation is essential for WNT-induced proliferation
of breast cancer cells. Mol Med Rep. 9:973–978. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ye Y, Long X, Zhang L, Chen J, Liu P, Li
H, Wei F, Yu W, Ren X and Yu J: NTS/NTR1 co-expression enhances
epithelial-to-mesenchymal transition and promotes tumor metastasis
by activating the Wnt/β-catenin signaling pathway in hepatocellular
carcinoma. Oncotarget. 7:70303–70322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu
LX, Zhang SH, Huang DD, Tang L, Kong XN, et al: Wnt/beta-catenin
signaling contributes to activation of normal and tumorigenic liver
progenitor cells. Cancer Res. 68:4287–4295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuan Z, Yu X, Ni B, Chen D, Yang Z, Huang
J, Wang J, Chen D and Wang L: Overexpression of long non-coding
RNA-CTD903 inhibits colorectal cancer invasion and migration by
repressing Wnt/β-catenin signaling and predicts favorable
prognosis. Int J Oncol. 48:2675–2685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baldwin LA, Hoff JT, Lefringhouse J, Zhang
M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, et al: CD151-α3β1
integrin complexes suppress ovarian tumor growth by repressing
slug-mediated EMT and canonical Wnt signaling. Oncotarget.
5:12203–12217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zou W, Zou Y, Zhao Z, Li B and Ran P:
Nicotine-induced epithelial-mesenchymal transition via
Wnt/β-catenin signaling in human airway epithelial cells. Am J
Physiol Lung Cell Mol Physiol. 304:L199–L209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu CC, Cai DL, Sun F, Wu ZH, Yue B, Zhao
SL, Wu XS, Zhang M, Zhu XW, Peng ZH and Yan DW: FERMT1 mediates
epithelial-mesenchymal transition to promote colon cancer
metastasis via modulation of β-catenin transcriptional activity.
Oncogene. 36:1779–1792. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu ZJ, Liu HL, Zhou HC and Wang GC: TIPE2
inhibits hypoxia-induced Wnt/β-catenin pathway activation and EMT
in glioma cells. Oncol Res. 24:255–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
